Haas, MR, Tschaut, N & Viney, RC 2009, 'Health insurance' in Fallon, M (ed), The law handbook: Your practical guide to the law in New South Wales 11th edition, Redfern Legal Centre, Redfern, pp. 843-849.
Hall, JP 2009, 'Health services research in Australia' in Mullner, RM (ed), Encyclopedia of Health Services Research, SAGE Publications, Inc, Chicago.
Chenoweth, L, King, MT, Jeon, Y-H, Brodaty, H, Stein-Parbury, J, Norman, R, Haas, M & Luscombe, G 2009, 'Caring for Aged Dementia Care Resident Study (CADRES) of person-centred care, dementia-care mapping, and usual care in dementia: a cluster-randomised trial', LANCET NEUROLOGY, vol. 8, no. 4, pp. 317-325.
View/Download from: Publisher's site
View description>>
Background: Evidence for improved outcomes for people with dementia through provision of person-centred care and dementia-care mapping is largely observational. We aimed to do a large, randomised comparison of person-centred care, dementia-care mapping, and usual care. Methods: In a cluster randomised controlled trial, urban residential sites were randomly assigned to person-centred care, dementia-care mapping, or usual care. Carers received training and support in either intervention or continued usual care. Treatment allocation was masked to assessors. The primary outcome was agitation measured with the Cohen-Mansfield agitation inventory (CMAI). Secondary outcomes included psychiatric symptoms including hallucinations, neuropsychological status, quality of life, falls, and cost of treatment. Outcome measures were assessed before and directly after 4 months of intervention, and at 4 months of follow-up. Hierarchical linear models were used to test treatment and time effects. Analysis was by intention to treat. This trial is registered with the Australia and New Zealand Clinical Trials Registry, number ACTRN12608000084381. Findings: 15 care sites with 289 residents were randomly assigned. Pairwise contrasts revealed that at follow-up, and relative to usual care, CMAI score was lower in sites providing mapping (mean difference 10·9, 95% CI 0·7-21·1; p=0·04) and person-centred care (13·6, 3·3-23·9; p=0·01). Compared with usual care, fewer falls were recorded in sites that used mapping (0·24, 0·08-0·40; p=0·02) but there were more falls with person-centred care (0·15, 0·02-0·28; p=0·03). There were no other significant effects. Interpretation: Person-centred care and dementia-care mapping both seem to reduce agitation in people with dementia in residential care. Funding: Australian Health Ministers' Advisory Council. © 2009 Elsevier Ltd. All rights reserved.
Fiebig, DG, Haas, M, Hossain, I, Street, DJ & Viney, R 2009, 'Decisions about Pap tests: What influences women and providers?', SOCIAL SCIENCE & MEDICINE, vol. 68, no. 10, pp. 1766-1774.
View/Download from: Publisher's site
View description>>
Despite the success internationally of cervical screening programs debate continues about optimal program design. This includes increasing participation rates among under-screened women, reducing unnecessary early re-screening, improving accuracy of and confidence in screening tests, and determining the cost-effectiveness of program parameters, such as type of screening test, screening interval and target group. For all these issues, information about consumer and provider preferences and insight into the potential impact of any change to program design on consumer and provider behaviour are essential inputs into evidence-based health policy decision making. This paper reports the results of discrete choice experiments to investigate women's choices and providers' recommendations in relation to cervical screening in Australia. Separate experiments were conducted with women and general practitioners, with attributes selected to allow for investigation of how women and general practitioners differ in their preferences for attributes of screening programs. Our results indicate a considerable commonality in preferences but the alignment was not complete. Women put relatively more weight on cost, chance of a false positive and if the recommended screening interval were changed to one year. © 2009 Elsevier Ltd. All rights reserved.
Gallego, G, van Gool, K & Kelleher, D 2009, 'Resource allocation and health technology assessment in Australia: Views from the local level', International Journal of Technology Assessment in Health Care, vol. 25, no. 02, pp. 134-140.
View/Download from: Publisher's site
View description>>
Objectives:Several studies have shown that a key determinant of successful health technology assessment (HTA) uptake is a clear, fair, and consistent decision-making process for the approval and introduction of health technologies. The aim of this study was to gauge healthcare providers' and managers' perceptions of local level decision making and determine whether these processes offer a conducive environment for HTA. An Area Health Service (AHS) aimed to use the results of this study to help design a new process of technology assessment and decision making.Methods:An online survey was sent to all health service managers and healthcare providers working in one AHS in Sydney, Australia. Questions related to perceptions of current health technology decisions in participants' own institution/facility and opinions on key criteria for successful decision-making processes.Results:Less than a third of participants agreed with the statements that local decision-making processes were appropriate, easy to understand, evidence-based, fair, or consistently applied. Decisions were reportedly largely influenced by total cost considerations as well as by the central state health departments and the Area executive.Conclusions:Although there are renewed initiatives in HTA in Australia, there is a risk that such investments will not be productive unless policy makers also examine the decision-making contexts within which HTA can successfully be implemented. The results of this survey show that this is especially true at the local level and that any HTA initiative should be accompanied by efforts to improve decision-making processes.
Kenny, P, Hall, J, King, M & Lancsar, E 2009, 'Sources of variation in the costs of health care for asthma patients in Australia', JOURNAL OF HEALTH SERVICES RESEARCH & POLICY, vol. 14, no. 3, pp. 133-140.
View/Download from: Publisher's site
View description>>
Objectives: Individuals with chronic conditions, such as asthma, on average incur high health care costs, though good control can reduce costs and improve health outcomes. However, there may be substantial variation between patients in their use of services and therefore costs. Our objective was to investigate the sources of such variation in health system and out-of-pocket costs for people with asthma. Methods: A longitudinal observational study of 252 people with asthma in New SouthWales, Australia, followed for three years, using six-monthly postal surveys and individual administrative data. Factors associated with costs were investigated using generalized linear mixed models. Results: There was substantial variability in costs between individuals but relatively little within-person change over time for the majority. Costs to the health system and out-of-pocket costs were higher with increasing asthma-related health problems and increasing age. Health system costs were less for patients living outside the state capital (Sydney) and for those in the middle income group relative to high and low income groups. Conclusions: Those with poorly-controlled asthma and the elderly require more carefully targeted strategies to improve their health and ensure appropriate use of resources. Access to appropriate services for those living outside of major cities should be improved. Co-payments for the middle-income groups and those living outside major cities should be reduced to improve equity in the use of services. © The Royal Society of Medicine Press Ltd 2009.
King, MT, Kenny, PM & Marks, GB 2009, 'Measures of asthma control and quality of life: longitudinal data provide practical insights into their relative usefulness in different research contexts', QUALITY OF LIFE RESEARCH, vol. 18, no. 3, pp. 301-312.
View/Download from: Publisher's site
View description>>
Purpose: To further our understanding of the relationships between asthma control and health-related quality of life (HRQOL) and provide insights into the relative usefulness of various measures in different research contexts. We present a conceptual model and test it with longitudinal survey data. Methods: Participants recruited via population sampling and hospital Emergency Departments completed questionnaires every 6 months for up to 3 years. Measures included: sleep disturbance, use of short-acting beta agonists (SABA), activity limitation, urgent medical visits, hospital use, Marks' Asthma Quality of Life Questionnaire (AQLQ-M) and the SF-36 Health Survey. Correlation analysis and multi-level models tested predictions from the conceptual model. Results: A total of 213 people with asthma aged 16-75 years provided 967 observations. Correlations between asthma control and asthma-specific HRQOL were stronger than those between asthma control and generic HRQOL. The asthma control variables explained 54-58% of the variance in asthma-specific HRQOL and 8-25% of the variance in generic HRQOL. Activity limitation was the main contributor to between-person variation, while sleep disturbance and SABA use were the main contributors to within-person variation. Conclusions: Sleep disturbance and SABA use may be most useful in evaluating treatment effectiveness, while activity limitation may be better when monitoring the impact of asthma in populations. © 2009 Springer Science+Business Media B.V.
King, MT, Viney, R, Hossain, I, Smith, D, Savage, E, Stockler, MR & Armstrong, B 2009, 'Survival gains needed to justify the side effects of treatment for localized prostate cancer', Journal of Clinical Oncology, vol. 27, no. 15_suppl, pp. 5119-5119.
View/Download from: Publisher's site
View description>>
5119 Background: Men diagnosed with localized prostate cancer face difficult treatment decisions. Evidence about the relative survival benefit of treatment options is lacking or piecemeal. Side-effects can vary widely with treatment, affecting some fundamental aspects of quality of life (QOL). Little is known about patients’ views of the relative tolerability of these side-effects or the survival gains needed to justify them. Methods: QOL data were collected prospectively 3 years post-diagnosis in a population-based cohort of men treated for localized prostate cancer (n=1642); these data were used to identify common side-effect profiles. A patient preference survey was conducted in a subset (n=357, stratified by treatment); hypothetical treatment alternatives were described in terms of side-effects and survival. Random parameter logit models were estimated. We adapted the concept of compensating variation from welfare economics to derive a parameter function for the value of changes in QOL in terms of survival time; i.e., the survival gains needed to justify persistent side-effects. Bootstrap confidence intervals (CI) were constructed. Results: The table shows the survival gains needed for a range of common treatment profiles, relative to the base case of active surveillance (in which men typically experienced mild loss of libido and mild fatigue). For example, radical prostatectomy often resulted in severe impotence and mild urinary leakage; men required an extra 8.0 months (95% CI 7.4–8.7) of life to make this worthwhile. Generally, urinary dysfunction and bowel symptoms were considered the least tolerable, hormonal symptoms and fatigue came next, and sexual dysfunction was considered relatively benign. This pattern was relatively consistent across treatment groups. Conclusions: These results highlight the need for better evidence about the actual survival benefits of alternative treatments. They also help to target supporti...
Lin, C & Haas, M 2009, 'The Assessment of Quality of Life (AQoL)', Australian Journal of Physiotherapy, vol. 55, no. 3, pp. 212-212.
View/Download from: Publisher's site
Mitchell, AS, Isaacs, D, Buttery, J & Viney, R 2009, 'Funding of drugs: do vaccines warrant a different approach?', The Lancet Infectious Diseases, vol. 9, no. 5, pp. 269-270.
View/Download from: Publisher's site
Mitchell, P, Pirkis, J, Hall, J & Haas, M 2009, 'Partnerships for knowledge exchange in health services research, policy and practice', JOURNAL OF HEALTH SERVICES RESEARCH & POLICY, vol. 14, no. 2, pp. 104-111.
View/Download from: Publisher's site
View description>>
Within the health services research community there is a growing strength of feeling that ongoing partnerships between researchers and decision-makers are critically important to effective transfer and exchange of knowledge generated from health services research. A body of literature is emerging around this idea that favours a particular model of partnership based on decision-maker involvement in research. This model is also gaining favour among health research funding bodies internationally. We argue that it is premature for the health services community to privilege any particular model of partnership between researchers and decision-makers. Rather a diversity of models should be conceptualized, explored in theory and practice, and evaluated. We identify seven dimensions that could be used to describe and differentiate models of partnerships for knowledge exchange and illustrate how these dimensions could be applied to analysing partnerships, using three case studies from recent and ongoing health services research partnerships in Australia. © The Royal Society of Medicine Press Ltd 2009.
Norman, R, Cronin, P, Viney, R, King, M, Street, D & Ratcliffe, J 2009, 'International Comparisons in Valuing EQ-5D Health States: A Review and Analysis', VALUE IN HEALTH, vol. 12, no. 8, pp. 1194-1200.
View/Download from: Publisher's site
View description>>
Objective: To identify the key methodological issues in the construction of population-level EuroQol 5-dimensions (EQ-5D)/time trade-off (TTO) preference elicitation studies. Method: This study involved three components. The first was to identify existing population-level EQ-5D TTO studies. The second was to illustrate and discuss the key areas of divergence between studies, including the international comparison of tariffs. The third was to portray the relative merits of each of the approaches and to compare the results of studies across countries. Results: While most articles report use of the protocol developed in the original UK study, we identified three key areas of divergence in the construction and analysis of surveys. These are the number of health states valued to determine the algorithm for estimating all health states, the approach to valuing states worse than immediate death, and the choice of algorithm. The evidence on international comparisons suggests differences between countries although it is difficult to disentangle differences in cultural attitudes with random error and differences as a result of methodological divergence. Conclusions: Differences in methods may obscure true differences in values between countries. Nevertheless, population-specific valuation sets for countries engaging in economic evaluation would better reflect cultural differences and are therefore more likely to accurately represent societal attitudes. © 2009, International Society for Pharmacoeconomics and Outcomes Research (ISPOR).
Norman, R, Haas, M & Wilcken, B 2009, 'International perspectives on the cost-effectiveness of tandem mass spectrometry for rare metabolic conditions', Health Policy, vol. 89, no. 3, pp. 252-260.
View/Download from: Publisher's site
View description>>
To examine and evaluate the economic evidence regarding the use of tandem mass spectrometry (MS/MS) for the detection of rare metabolic conditions in neonates, and then to consider the transferability of these national-level results to other decision-making contexts. Methods A systematic literature review was undertaken, identifying papers published between January 1997 and March 2008. Thirteen unique cost-effectiveness evaluations were identified and appraised for comparability and transferability of results across settings.
Norman, R, Haas, M, Chaplin, M, Joy, P & Wilcken, B 2009, 'Economic Evaluation of Tandem Mass Spectrometry Newborn Screening in Australia', PEDIATRICS, vol. 123, no. 2, pp. 451-457.
View/Download from: Publisher's site
View description>>
OBJECTIVE. The goal was to investigate the cost-effectiveness of tandem mass spectrometry screening for the detection of inborn metabolic errors in an Australian setting. METHODS. Cost-effectiveness analysis from the health service perspective was undertaken on the basis of registry data for affected individuals. The intervention group was contrasted with both a contemporaneous group in nonscreening states and a historical cohort. The registry covers all individuals identified in Australia between 1994 and 2002. Main outcome measures were the total net cost of screening, the cost of treatment, life-years saved, and deaths averted. RESULTS. The total net cost of testing was estimated to be A$218 000 per 100 000 infants. Medical costs incurred by the intervention group exceeded those for the control group by A$131 000 per 100 000 infants. The number of life-years saved per 100 000 infants screened was 32.378 life-years per 100 000 infants through an expected mortality rate reduction of 0.738 deaths per 100 000 infants. The cost per death averted was estimated to be A$472 913 and the cost per life-year saved was estimated to be A$10 779, which compare favorably with existing cost-effectiveness standards. This conclusion is particularly robust because conservative assumptions were made throughout, because of data limitations. Sensitivity analyses suggested that this result was relatively robust to adjustment of model parameters.
Page, L & Page, K 2009, 'Stakes and Motivation in Tournaments: Playing When There is Nothing to Play for but Pride', Economic Analysis and Policy, vol. 39, no. 3, pp. 455-464.
View/Download from: Publisher's site
View description>>
© 2009 Economic Society of Australia (Queensland) Inc. Tournaments are an effective means of incentivising participants to ensure an optimal level of effort. However, situations can occur in tournaments where the final outcome of a given competitor does not depend on his/her future performance. Specifically, we study these specific situations in a data set of the group stages of European football club competitions from 1992 to 2009. We identify situations where teams are already sure to finish either first or last at the penultimate stage in the group. We show that such situations affect team performance in the last match, typically decreasing the performance of a team sure to finish first and increasing the performance of a team sure to finish last. The first finding is in line with the economic predictions yet provides interesting implications, namely that the schedule of the match order plays a significant role in the overall performance of the team. The second, counter-intuitive, finding is not well accommodated into the existing economics framework and thus we discuss two alternative explanations, one based on social pressure and the other on pride.
Twigg, E, Barkham, M, Bewick, BM, Mulhern, B, Connell, J & Cooper, M 2009, 'The Young Person's CORE: Development of a brief outcome measure for young people', Counselling and Psychotherapy Research, vol. 9, no. 3, pp. 160-168.
View/Download from: Publisher's site
View description>>
AbstractBackground: There is a need for a user‐friendly measure of change for use in school and youth counselling services which is easy for practitioners to administer and score, and which is appropriate for brief interventions. Aims: To develop such a measure and to present psychometric data on reliability, validity and sensitivity to change for the measure. Method: We employed a three‐stage approach: first, creating a pool of potential items; second, developing an 18‐item version; and third, refining to a final version comprising 10 items. We called the measure the Young Person's CORE (YP‐CORE). Results: The measure comprised eight negative and two positive items and included a single (negatively‐framed) risk‐to‐self item. Psychometric properties were all acceptable. Sensitivity to change was good and yielded an average improvement of 10 points on the YP‐CORE in a clinical group, broadly equivalent to changes in adult versions (e.g. Clinical Outcomes in Routine Evaluation – Outcome Measure (CORE‐OM)). Conclusion: Initial validation work showed the measure to be well designed and sensitive to change. Analysis showed considerable variability as a function of age and gender suggesting the need for the collection of a large and diverse data set in order to produce gender and age‐specific norms.
Wilcken, B, Haas, M, Joy, P, Wiley, V, Bowling, F, Carpenter, K, Christodoulou, J, Cowley, D, Ellaway, C, Fletcher, J, Kirk, EP, Lewis, B, McGill, J, Peters, H, Pitt, J, Ranieri, E, Yaplito-Lee, J & Boneh, A 2009, 'Expanded newborn screening: outcome in screened and unscreened patients at age 6 years.', Pediatrics, vol. 124, no. 2, pp. e241-e248.
View/Download from: Publisher's site
View description>>
OBJECTIVE: Tandem mass spectrometry is widely applied to routine newborn screening but there are no long-term studies of outcome. We studied the clinical outcome at six years of age in Australia. METHODS: In a cohort study, we analyzed the outcome at 6 years for patients detected by screening or by clinical diagnosis among >2 million infants born from 1994 to 1998 (1,017,800, all unscreened) and 1998 to 2002 (461,500 screened, 533,400 unscreened) recording intellectual and physical condition, school placement, other medical problems, growth, treatment, diet, and hospital admissions. Results were analyzed separately for medium-chain acyl-CoA dehydrogenase deficiency (MCADD) and other disorders, and grouped patients as those who presented clinically or died in the first 5 days of life; patients presented later or diagnosed by screening, and those with substantially benign disorders. RESULTS: Inborn errors, excluding phenylketonuria, were diagnosed in 116 of 1,551,200 unscreened infants (7.5/100,000 births) and 70 of 461,500 screened infants (15.2/100,000 births). Excluding MCADD, 21 unscreened patients with metabolic disorders diagnosed after 5 days of life died or had a significant intellectual or physical handicap (1.35/100,000 population) compared with 2 of the screened cohort (0.43/100,000; odds ratio: 3.1 [95% CI: 0.73-13.32]). Considering the likely morbidity or mortality among the expected number of never-diagnosed unscreened patients, there would be a significant difference. Growth distribution was normal in all cohorts. CONCLUSION: Screening by tandem mass spectrometry provides a better outcome for patients at 6 years of age, with fewer deaths and fewer clinically significant disabilities.
Church, J, Sassi, F, Devaux, M, Cecchini, M & Borgonovi, F 1970, 'Education and obesity in four OECD countries: UK, Australia, Canada and Korea', 6th Health Services and Policy Conference 2009, Brisbane.
Cronin, PA, Goodall, S, Norman, R & Church, J 1970, 'The impact of improving screening participation rate and diagnostic test sensitivity on colorectal cancer screening', 6th Health Services and Policy Research Conference 2009, Brisbane.
Cronin, PA, Norman, R, King, MT, Clarke, D, Viney, RC & Street, D 1970, 'Does mode of administration matter? Comparison of online and face to face administration of a time trade-off task', Brisbane.
Cronin, PA, Norman, R, Viney, RC, King, MT, Street, D, Burgess, LB, Brazier, JE & Ratcliffe, J 1970, 'Can Time Trade Off be implemented online? A case study from Australia using the EQ-5D (Poster)', iHEA 7th World Congress, Beijing, China.
De Abreu Lourenco, R 1970, 'A time-trade-off study comparing intramuscular and subcutaneous administration of octreotide for acromegaly or carcinoid syndrome', New Orleans.
Faedo, M, Pearson, S, Bastick, P, Van Gool, K, Haywood, P, Haas, MR & Ward, R 1970, 'Elements of Care Study: Tracking resource utilisation and costs in a cohort of NSW cancer patients', 6th Health Services and Policy Conference 2009, Brisbane.
Gallego, G, Van Gool, K, Haas, MR & Tannous, K 1970, 'Once upon a time in a land far far away: the evidence on early childhood intervention programs and its relevance to the here and now', Australian Conference of Health Economists, Hobart.
Goodall, S & Scott, T 1970, 'Is hospital treatment in Australia inequitable? Evidence from HILDA, a large nationally representative household-based panel survey', iHEA 7th World Congress, Beijing, China.
Haas, MR, Ashton, T, Christiansen, T, Crivelli, L, Conis, E, Lim, M, McAdam, C, Lisac, M, Blum, K & Schlette, S 1970, 'Drugs, Sex, Money and Power: an HPV case study', Academy Health Annual Research Meeting, Chicago, USA.
Haas, MR, Van Gool, K, de Raad, J, Haywood, P & Ward, R 1970, 'The Cost of Administering Chemotherapy', iHEA 7th World Congress, Beijing, China.
Haas, MR, Viney, RC, Gallego, G & Hall, JP 1970, 'Implementing guidelines for reimbursement in Australia: How the PBAC & MSAC use comparative cost-effectiveness', International Network Health Policy and Reform Meeting, Krakow, Poland.
Haas, MR, Ward, R, Van Gool, K, Hall, JP, Stewart, B, Pearson, S, Links, M & Board, N 1970, 'Economic Modelling applied to Cancer Protocols: EM-CAP', 6th Health Services and Policy Research Conference 2009, Brisbane.
Hall, JP 1970, 'Does management matter? Australian management practices research project', Royal Australian College of Medical Administrators Annual Conference, Citygate Central, Sydney.
Hall, JP 1970, 'Health and Hospitals Reform Commission: 'New Models of Care' Discussant', Australian Financial Review Health Conference 2009, Sydney.
Haywood, P, de Raad, J, Van Gool, K, Gallego, G & Haas, MR 1970, 'Estimating the costs of administering chemotherapy', 6th Health Services and Policy Research Conference 2009, Brisbane.
Hossain, I, Hall, JP, Fiebig, DG & King, MT 1970, 'How do preferences elicited through DCEs vary over time and with changing experience? The case of preferences for asthma medications', iHEA 7th World Congress, Beijing, China.
Johar, M, Fiebig, DG, Haas, MR & Viney, RC 1970, 'Evaluating changes in women's attitudes towards cervical screening following a screening promotion campaign and a free vaccination', 6th Health Services and Policy Research Conference 2009, Brisbane.
Kenny, PM, Hall, JP, Hossain, I & Savage, EJ 1970, 'Supporting palliative care informal carers: Preferences and value of services', 6th Health Policy and Research Conference 2009, Brisbane.
King, MT, Viney, R, Hossain, I, Smith, D, Savage, E, Stockler, MR & Armstrong, B 1970, 'Survival gains needed to justify the side effects of treatment for localized prostate cancer', JOURNAL OF CLINICAL ONCOLOGY, 45th Annual Meeting of the American-Society-of-Clinical-Oncology, AMER SOC CLINICAL ONCOLOGY, Orlando, FL.
Knox, SA, Street, D, King, MT, Boyle, F, Wilcken, N & Butow, P 1970, 'Preferences of women with early stage breast cancer for administration of targeted HER2 therapy: Designing a discrete choice experiment', Australian and New Zealand Breast Cancer Trials Group, 31st Annual Scientific Meeting, Darwin, NT.
Knox, SA, Viney, RC, Street, D, Haas, MR, Weisberg, E & Bateson, D 1970, 'Do women and GPs agree in their preferences around contraceptive methods?', 6th Health Services and Policy Conference 2009, Brisbane.
Lourenco, DAR, Colman, S & Lee, C 1970, 'THALIDOMIDE PLUS MELPHALAN AND PREDNISONE FOR AUSTRALIAN PATIENTS NEWLY DIAGNOSED WITH MULTIPLE MYELOMA IS COST-EFFECTIVE WHEN COMPARED WITH MELPHALAN AND PREDNISONE ALONE', VALUE IN HEALTH, WILEY-BLACKWELL PUBLISHING, INC, pp. A381-A381.
Norman, R, Gallego, G, Goodall, S & Hall, JP 1970, 'Equity weights for economic evaluation: Using Discrete Choice Experiments in an Australian population', iHEA 7th World Congress, Beijing, China.
Owen, KM, Pettman, TL, Haas, MR, Viney, RC & Misan, GM 1970, 'Individual preferences for diet and exercise programs: changes over a lifestyle intervention and their link with outcomes', Australian Conference of Health Economists, Hobart.
Pearce, AM, Haas, MR, Haywood, P, Van Gool, K, Gallego, G, Pearson, S, Faedo, M & Ward, R 1970, 'Chemotherapy, adverse events and costs', 6th Health Services and Policy Conference 2009, Brisbane.
Pearson, S, Faedo, M, Van Gool, K, Haas, MR & Ward, R 1970, 'Using routinely collected health data to inform economic models of cancer care', 6th Health Services and Policy Research Conference 2009, Brisbane.
Savage, EJ & Van Gool, K 1970, 'The Medicare Safety Net and the ART of billing', 6th Health Services and Policy Research Conference 2009, Brisbane.
Van Gool, K, Savage, EJ & Viney, RC 1970, 'The impact of out-of-pocket costs on cervical screening: Evidence from an Australian panel dataset', iHEA 7th World Congress, Beijing, China.
Van Gool, K, Vu, M, Savage, EJ, Haas, MR & Birch, S 1970, 'Breast screening in New South Wales, Australia: Predictors of regular attendance', iHEA 7th World Congress, Beijing, China.
Viney, RC, Norman, R, Street, D, King, MT, Burgess, LB, Brazier, JE & Ratcliffe, J 1970, 'Application of discrete choice experiments to value multi-attribute health states: experimental design issues', iHEA 7th World Congress, Beijing, China.
Savage, EJ, Van Gool, K, Haas, MR, Viney, RC & Vu, M Department of Health & Ageing 2009, Extended Medicare safety net review report 2009 : a report by CHERE prepared for the Australian Government Department of Health & Ageing, pp. 1-80, Canberra.
Cronin, PA, Haas, MR, Savage, EJ & Vu, M 2009, 'Misperceptions of body mass: Analysis of NSW Health Survey 2003. CHERE Working Paper 2009/7'.
Gool, KV, Haas, M, Gallego, G, Tannous, K & Katz, I 2009, 'Framework for the cost benefit analysis of the NSW Department of Community Services Brighter Futures Program. CHERE Working Paper 2009/4.', CHERE Working Paper 2009/4.
View description>>
Brighter Futures is the NSW DOCS early intervention program targeting children aged 0 to 8. The program is designed to ?support pregnant women and families with young children aged 0-8 years who require long-term support (up to two years) by a range of services. The program gives particular priority to those families with children under three years.? (Department of Community Services, 2007). To be able to access the Brighter Futures program, parents must also have a vulnerability that is likely to worsen if not addressed with the services and support available to the parents and children which include home visits, quality children?s services and a parenting program (Department of Community Services, 2007).A Consortium led by the Social Policy Research Centre, and including the Centre for Health Economics Research and Evaluation (CHERE) at UTS and Pamela Meadows from the National Institute of Economic and Social Research, has been commissioned to undertake the evaluation of all aspects of the program. An important component of the evaluation process is economic evaluation. This paper is set out as follows; Section 2 provides a brief introduction to economic appraisal in relation to the Brighter Futures program and sets out the links between the envisaged cost-effectiveness analysis (CEA) and cost benefit analysis (CBA). It also outlines the broad challenges faced when undertaking economic appraisals in the field of program such as Brighter Futures. Section 3 sets out a methodological framework for undertaking the CBA of the Brighter Futures program, including methods for addressing key evaluation challenges and Section 4 outlines the main tasks for the CBA work.
Haas, M, Hall, J & Gallego, G 2009, 'Evidence for funding, organising and delivering health care services targeting secondary prevention and management of chronic conditions. CHERE Working Paper 2009/6'.
View description>>
This paper is designed as an issues paper. Its aim is to set out what evidence is available regarding the effectiveness and efficiency of funding, organisation and delivery of services directed at preventing and managing chronic conditions, and identify what further information is required. The latter will then be used as a means of identifying gaps in information which can be addressed by research. The information is not presented as a comprehensive review of all available evidence but as a preliminary scoping of the results of the most recent literature.
Johar, M, Fiebig, D, Haas, M & Viney, R 2009, 'Evaluating changes in women's attitudes towards cervical screening following a screening promotion campaign and a free vaccination program. CHERE Working Paper 2009/3', CHERE Working Paper.
View description>>
This study examines behavioural changes brought about by two interventions introduced to lower the incidence of cervical cancer in Australia. The first intervention is a media campaign promoting regular screening behaviour to women. The second intervention is a vaccination program providing a free HPV vaccine, Gardasil, to young women launched in the same period. The results using data from discrete choice experiments find that in general, given individual characteristics, the interventions have minor impact on how women value screening attributes. The interventions however alter women?s inherent taste for screening. Unexpectedly, willingness to screen is generally lower post-interventions. The reason for this trend appears to be related to HPV events. For instance, the reduction in screening participation is particularly marked among young women who are eligible for the vaccination program. There is also a larger aversion towards testing among women who gained information on HPV facts and HPV-related measures. Thus, in the face of HPV innovations, screening promotions need to account for these factors. A simulation exercise is then performed to assess the plausibility of several strategies to increase the screening rate. The results nominate supply-side policies, in particular those targeted to health providers, as the most effective strategy.
